<DOC>
	<DOCNO>NCT00730145</DOCNO>
	<brief_summary>1 . Quantify much PD-0332334 remove blood hemodialysis 2 . Investigate pharmacokinetics single dose PD-0332334 subject receive regular hemodialysis treatment . 3 . Investigate safety tolerability single dose PD-0332334 subject receive hemodialysis .</brief_summary>
	<brief_title>A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis</brief_title>
	<detailed_description>Assess elimination PD-0332334 blood hemodialysis</detailed_description>
	<criteria>Patients receive regular hemodialysis Male female patient 18 65 year Severe heart failure Renal transplant renal allograft Illicit drug use ( exception prescribe sedative )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>pharmacokinetics , PD-0332334 , hemodialysis , renal dialysis</keyword>
</DOC>